Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS)
CNY 4.5
(-0.66%)
CNY 4.5
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.73 Billion | 3.68 Billion | 3.74 Billion | 3.11 Billion | 2.91 Billion | 2.42 Billion |
| Cost of Revenue | 2.07 Billion | 1.87 Billion | 1.96 Billion | 1.68 Billion | 1.51 Billion | 1.2 Billion |
| Gross Profit | 1.65 Billion | 1.81 Billion | 1.78 Billion | 1.43 Billion | 1.39 Billion | 1.21 Billion |
| Operating Expenses | 1.58 Billion | 1.56 Billion | 1.54 Billion | 1.21 Billion | 1.05 Billion | 910.6 Million |
| Selling, General and Administrative Expenses | 1.26 Billion | 1.23 Billion | 1.24 Billion | 919.9 Million | 765.71 Million | 697.06 Million |
| Research and Development Expenses | 161.12 Million | 142.65 Million | 133.34 Million | 138.06 Million | 129.39 Million | 102.85 Million |
| Other Expenses | 36.5 Million | 184.72 Million | 172.19 Million | 152.84 Million | 159.97 Million | -2.09 Million |
| Cost and Expenses | 3.61 Billion | 3.44 Billion | 3.5 Billion | 2.89 Billion | 2.57 Billion | 2.11 Billion |
| Operating Income | 169.4 Million | 185.66 Million | 248.05 Million | 197.68 Million | 340.89 Million | 232.66 Million |
| Interest Expense | 36.68 Million | 48.18 Million | 45.87 Million | 40.19 Million | 36.68 Million | 22.32 Million |
| Income Tax Expense | 5.56 Million | -5.92 Million | 40.39 Million | 31.8 Million | 69.83 Million | 33.61 Million |
| Earnings before Tax | 168.23 Million | 12.51 Million | 149.06 Million | 112.38 Million | 253.04 Million | 230.57 Million |
| Net Income | 117.05 Million | 18.43 Million | 108.66 Million | 80.57 Million | 145.27 Million | 153.45 Million |
| Earnings Per Share Basic | 0.11 | 0.02 | 0.10 | 0.07 | 0.15 | 0.14 |
| Earnings Per Share Diluted | 0.11 | 0.02 | 0.10 | 0.07 | 0.15 | 0.14 |
| Weighted Average Shares Outstanding | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion |
| Gross Margin | 0.44 | 0.49 | 0.48 | 0.46 | 0.48 | 0.50 |
| EBIT Margin | 0.13 | 0.12 | 0.12 | 0.12 | 0.17 | 0.18 |
| Profit Margin | 0.03 | 0.00 | 0.03 | 0.03 | 0.05 | 0.06 |
| EBITDA | 479.02 Million | 321.66 Million | 403.74 Million | 341.21 Million | 502.02 Million | 371.36 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.07 | 0.06 | 0.12 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 771.23 Million | 937.21 Million | 863.76 Million | 933.41 Million | 3.73 Billion | 814.51 Million |
| Cost of Revenue | 460.56 Million | 493.36 Million | 475.51 Million | 597.64 Million | 2.1 Billion | 454.8 Million |
| Gross Profit | 310.66 Million | 443.85 Million | 388.25 Million | 335.77 Million | 1.62 Billion | 359.71 Million |
| Operating Expenses | 239.55 Million | 308.93 Million | 274.3 Million | 396.1 Million | 1.46 Billion | 310.01 Million |
| Selling, General and Administrative Expenses | 287.98 Million | 185.04 Million | 231.06 Million | 348.32 Million | - | 347.48 Million |
| Research and Development Expenses | 51.97 Million | 44.87 Million | 38.96 Million | 33.4 Million | - | 39.97 Million |
| Other Expenses | -100.4 Million | 241.93 Thousand | 1.41 Million | -14.37 Million | -49.04 Million | -80.96 Thousand |
| Cost and Expenses | 700.12 Million | 802.29 Million | 749.81 Million | 993.75 Million | 3.57 Billion | 764.82 Million |
| Operating Income | 60.75 Million | 114.47 Million | 78.19 Million | -60.33 Million | 160.84 Million | 42.63 Million |
| Interest Expense | 7.05 Million | 7.33 Million | 8.46 Million | 7.62 Million | 36.68 Million | 7.63 Million |
| Income Tax Expense | -417.35 Thousand | 9.79 Million | 7.13 Million | -11.64 Million | 5.56 Million | 3.9 Million |
| Earnings before Tax | 61.04 Million | 114.71 Million | 79.61 Million | -42.56 Million | 168.5 Million | 42.55 Million |
| Net Income | 44.67 Million | 84 Million | 58.01 Million | -34.69 Million | 117.05 Million | 28.34 Million |
| Earnings Per Share Basic | 0.04 | 0.08 | 0.05 | -0.03 | - | 0.03 |
| Earnings Per Share Diluted | 0.04 | 0.08 | 0.05 | -0.03 | - | 0.03 |
| Weighted Average Shares Outstanding | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion |
| Gross Margin | 0.40 | 0.47 | 0.45 | 0.36 | 0.44 | 0.44 |
| EBIT Margin | 0.09 | 0.15 | 0.14 | 0.01 | - | 0.06 |
| Profit Margin | 0.06 | 0.09 | 0.07 | -0.04 | 0.03 | 0.03 |
| EBITDA | 68.09 Million | 143 Million | 121.15 Million | 8.94 Million | - | 52.24 Million |
| Earnings Before Tax Margin | 0.08 | 0.12 | 0.09 | -0.06 | 0.04 | 0.05 |
LINK
CEVA
7725
HSDT
CPHC
9595